[Federal Register Volume 63, Number 58 (Thursday, March 26, 1998)]
[Rules and Regulations]
[Pages 14612-14613]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-7835]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 510
New Animal Drugs; Change of Sponsor Address
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is amending the animal
drug regulations to reflect a change of sponsor address for Koffolk,
Inc.
EFFECTIVE DATE: March 26, 1998.
FOR FURTHER INFORMATION CONTACT: Thomas J. McKay, Center for Veterinary
Medicine (HFV-102), Food and Drug Administration, 7500 Standish Pl.,
Rockville, MD 20855, 301-827-0213.
SUPPLEMENTARY INFORMATION: Koffolk, Inc., One Parker Plaza, Fort Lee,
NJ 07024, has informed FDA of a change of sponsor address to P.O. Box
675935, 14735 Las Quintas, Rancho Santa Fe, CA 92067. Accordingly, the
agency is amending the regulations in 21 CFR 510.600(c)(1) and (c)(2)
to reflect the change of sponsor address.
List of Subjects in 21 CFR Part 510
Administrative practice and procedure, Animal drugs, Labeling,
Reporting and recordkeeping requirements.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under
authority delegated to the Commissioner of Food and Drugs and
redelegated to the Center for Veterinary Medicine, 21 CFR part 510 is
amended as follows:
PART 510--NEW ANIMAL DRUGS
1. The authority citation for 21 CFR part 510 continues to read as
follows:
Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.
2. Section 510.600 is amended in the table in paragraph (c)(1) by
revising the sponsor address for ``Koffolk, Inc.'' and in the table in
paragraph (c)(2) in the entry for ``063271'' by revising the sponsor
address to read as follows:
Sec. 510.600 Names, addresses, and drug labeler codes of sponsors of
approved applications.
* * * * *
(c) * * *
(1) * * *
------------------------------------------------------------------------
Firm name and address Drug labeler code
------------------------------------------------------------------------
* * * *
* * *
Koffolk, Inc., P.O. Box 675935, 14735 Las 063271
Quintas, Rancho Santa Fe, CA 92067.
* * * *
* * *
------------------------------------------------------------------------
(2) * * *
------------------------------------------------------------------------
Drug labeler code Firm name and address
------------------------------------------------------------------------
* * * *
* * *
063271................................... Koffolk, Inc., P.O. Box
675935, 14735 Las Quintas,
Rancho Santa Fe, CA 92067.
* * * *
* * *
------------------------------------------------------------------------
[[Page 14613]]
Dated: March 17, 1998.
Andrew J. Beaulieau,
Acting Director, Office of New Animal Drug Evaluation, Center for
Veterinary Medicine.
[FR Doc. 98-7835 Filed 3-25-98; 8:45 am]
BILLING CODE 4160-01-F
